Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

15 Biggest Mid-Day Losers For Monday

DXLG, BG, AGXRW, PULM, TOPS, QUIK, ARRY, CAL

  • Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 61.5 percent to $1.28. Cerulean Pharma and Daré Bioscience reported that they have entered into a stock purchase agreement. Cerulean also announced plans to reduce workforce by 11 people. The company reported that it has sold CRLX101 and CRLX301 to BlueLink Pharmaceuticals for $1.5 million and also agreed to sell Dynamic Tumor Targeting Platform to Novartis for $6 million.
  • Medgenics Inc (NASDAQ: GNMX) shares tumbled 55 percent to $2.45 after the company disclosed that that SAGA trial of AEVI-001 did not meet primary endpoint.
  • TOP SHIPS Inc (NASDAQ: TOPS) shares dropped 22.3 percent to $1.53 after declining 10.45 percent on Friday.
  • DryShips Inc. (NASDAQ: DRYS) shares fell 18 percent to $1.37. On Friday, DryShips reported the successful completion of the $200.0 million common stock offering.
  • Ritter Pharmaceuticals Inc (NASDAQ: RTTR) shares declined 15 percent to $1.92.
  • Trans World Entertainment Corporation (NASDAQ: TWMC) shares dropped 11.7 percent to $2.08.
  • QuickLogic Corporation (NASDAQ: QUIK) shares fell 10.3 percent to $2.10. QuickLogic reported a $15 million share offering.
  • Pulmatrix Inc (NASDAQ: PULM) shares declined 10 percent to $2.78 after the company reported up to $11 million at-the-market sales agreement with BTIG on Friday.
  • Agile Therapeutics Inc (NASDAQ: AGRX) shares dropped 6.1 percent to $2.76 after gaining 9.29 percent on Friday.
  • Array Biopharma Inc (NASDAQ: ARRY) slipped 5.6 percent to $9.97 after the company disclosed that it has withdrawn its NDA for Binimetinib.
  • Caleres Inc (NYSE: CAL) shares declined 4.5 percent to $26.69. Susquehanna downgraded Caleres from Positive to Neutral.
  • Destination XL Group Inc (NASDAQ: DXLG) shares fell 4.4 percent to $2.30. Destination XL Group reported Q4 earnings of $0.04 per share on revenue of $122.64 million. The company projects full-year loss of $0.14 per share to a loss of $0.06 per share, and revenue of $470 million to $480 million. Destination XL reported a $12 million buyback plan.
  • Mechel PAO (ADR) (NYSE: MTL) shares declined 4.4 percent to $5.21 after rising 11.45 percent on Friday.
  • Bunge Ltd (NYSE: BG) shares fell 3.4 percent to $79.07. Goldman Sachs downgraded Bunge from Buy to Neutral.
  • Sonic Corporation (NASDAQ: SONC) dropped 2.2 percent to $23.27. Canaccord Genuity downgraded Sonic from Buy to Hold.

Latest Ratings for CERU

Date Firm Action From To
Aug 2016 Barclays Maintains Overweight
Aug 2016 Wedbush Downgrades Outperform Neutral
Aug 2016 Leerink Swann Downgrades Outperform Market Perform

View More Analyst Ratings for CERU
View the Latest Analyst Ratings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today